Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

Author： Taneja S.S.   Pierce W.   Figlin R.   Belldegrun A.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.45, Iss.6, 1995-06, pp. : 911-924

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy for Renal Cell Carcinoma

By Bleumer I.   Oosterwijk E.   De Mulder P.   Mulders P.F.A.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 65-75

Elsevier

Access to resources Recommend Favorite

Serum Levels of Soluble Interleukin-2 Receptor in Renal Cell Carcinoma

By Matsumoto T.   Furukawa A.   Sumiyoshi Y.   Akiyama K.-y.   Kanayama H.-o.   Kagawa S.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 145-149

Elsevier

Access to resources Recommend Favorite

Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot study - permeability studies

By Walther M.M.   Lyne J.C.   Libutti S.K.   Linehan W.M.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 496-501

Elsevier

Access to resources Recommend Favorite

T-cell adoptive immunotherapy of metastatic renal cell carcinoma

By Plautz G.E.   Bukowski R.M.   Novick A.C.   Klein E.A.   Kursh E.D.   Olencki T.E.   Yetman R.J.   Pienkny A.   Sandstrom K.   Shu S.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 617-623

Elsevier

Access to resources Recommend Favorite

Pretreatment with Interleukin-2 Modulates Peri-Operative Immuno-Dysfunction in Patients with Renal Cell Carcinoma

By Bohm M.   Ittenson A.   Schierbaum K.F.   Rohl F.-W.   Ansorge S.   Allhoff E.P.  

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 458-468

Elsevier

Access to resources Recommend Favorite